Trihale

Fluticasone Furoate , Umeclidinium Bromide and Vilanterol Trifenatate

RESPIRATORY

INDICATION

Trihale is indicated for the maintenance treatment of patients with Asthma & Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and/or emphysema.

DOSAGE AND ADMINISTRATION

Route of Administration: Inhalation Capsule
The capsules are intended for use with ACMEs Easyhaler. While using with the ACMEs Easyhaler, the capsules will be pierced and will be ready to use.

18 years and older:
Trihale 100: One Rotacap once daily.
Trihale 200: One Rotacap once daily.

Trihale should be used at the same time every day. Do not use Trihale more than 1 time in every 24 hours.
OR, AS DIRECTED BY PHYSICIAN.

COMPOSITION

Trihale 100: Each capsule contains Fluticasone Furoate INN 100 mcg, Umeclidinium Bromide INN equivalent to 62.5 mcg of Umeclidinium and Vilanterol Trifenatate INN equivalent to 25 mcg of Vilanterol.

Trihale 200: Each capsule contains Fluticasone Furoate INN 200 mcg, Umeclidinium Bromide INN equivalent to 62.5 mcg of Umeclidinium and Vilanterol Trifenatate INN equivalent to 25 mcg of Vilanterol.